Skip to main content
. 2019 Feb 8;60(4):880–891. doi: 10.1194/jlr.M092544

Fig. 5.

Fig. 5.

Effects of HSD and Ces1d deficiency on regulatory hepatic LD metabolic genes/enzymes. A: Hepatic mRNA expression of genes involved in FA oxidation in fasted WT and Ces1d−/− mice (N = 6). B: Hepatic mRNA expression of ATGL inhibitor, G0s2 (N = 6). C: Protein abundance of PLIN2, PLIN5, and ATGL coactivator CGI-58 in the liver of WT and Ces1d−/− mice was assessed by immunoblotting. D: Protein abundance of ATGL and LD-associated protein. CIDEB. in the liver of WT and Ces1d−/− mice was assessed by immunoblotting. E: Hepatic mRNA expression of LD-associated proteins, CIDEA, CIDEB, and CIDEC (N = 6). F: Hepatic mRNA expression of Fgf21 (N = 6). Values are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.